Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Mol Neurobiol. 2018 Jul 28;56(4):2703–2713. doi: 10.1007/s12035-018-1266-7

Figure 3.

Figure 3

CSPGs alter levels of miRNAs and proteins in distal axons. Quantitative RT-PCR and Western blot analysis show increased miRNAs (A) and reduced proteins (B), respectively; and decreased miRNAs (C) and augmented proteins (D), respectively, in distal axons treated with CSPGs compared to control group without the CSPGs treatment. *p<0.05, and **p<0.01, n=3/group.